Bio-Rad Laboratories BIO
NYSE BIO
$380.03 +3.57 (+0.95%)
At close: Aug 21, 2026 · 4:00 PM EDT

Bio-Rad Laboratories (BIO) Return on Sales Growth (5y) (2014 - 2026)

Bio-Rad Laboratories (BIO) Return on Sales Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn
10 Bio-Rad Laboratories 10.23 Bn 8.61 Bn 345.80 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.00
Mar 31, 2026 -2.00
Dec 31, 2025 0.00
Sep 30, 2025 -3.00
Jun 30, 2025 -1.00
Mar 31, 2025 -1.00
Dec 31, 2024 -2.00
Sep 30, 2024 1.00
Jun 30, 2024 -4.00
Mar 31, 2024 -1.00
Dec 31, 2023 2.00
Sep 30, 2023 0.00
Jun 30, 2023 -2.00
Mar 31, 2023 -1.00
Dec 31, 2022 1.00
Sep 30, 2022 0.00
Jun 30, 2022 -1.00
Mar 31, 2022 -5.00
Dec 31, 2021 -2.00
Sep 30, 2021 5.00